Zoberi I - Search Results

1

Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines.

Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, Gius D. Zoberi I, et al. Cancer Lett. 2002 Jan 25;175(2):165-73. doi: 10.1016/s0304-3835(01)00719-4. Cancer Lett. 2002. PMID: 11741744

2

Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase.

Bradbury CM, Markovina S, Wei SJ, Rene LM, Zoberi I, Horikoshi N, Gius D. Bradbury CM, et al. Among authors: zoberi i. Cancer Res. 2001 Oct 15;61(20):7689-96. Cancer Res. 2001. PMID: 11606413

3

Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells.

Bisht KS, Bradbury CM, Zoberi I, Curry HA, Kaushal A, Roti Roti JL, Gius D. Bisht KS, et al. Among authors: zoberi i. Int J Radiat Biol. 2003 Nov;79(11):879-88. doi: 10.1080/09553000310001621400. Int J Radiat Biol. 2003. PMID: 14698956

4

Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.

Grigsby PW, Mutch DG, Rader J, Herzog TJ, Zoberi I, Siegel BA, Dehdashti F. Grigsby PW, et al. Among authors: zoberi i. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):444-9. doi: 10.1016/j.ijrobp.2004.05.046. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667965

5

Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer.

Malyapa RS, Mutic S, Low DA, Zoberi I, Bosch WR, Laforest R, Miller TR, Grigsby PW. Malyapa RS, et al. Among authors: zoberi i. Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1140-6. doi: 10.1016/s0360-3016(02)03043-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12419441

6

PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study.

Mutic S, Malyapa RS, Grigsby PW, Dehdashti F, Miller TR, Zoberi I, Bosch WR, Esthappan J, Low DA. Mutic S, et al. Among authors: zoberi i. Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):28-35. doi: 10.1016/s0360-3016(02)03804-x. Int J Radiat Oncol Biol Phys. 2003. PMID: 12504033

7

Lymph node control in cervical cancer.

Grigsby PW, Singh AK, Siegel BA, Dehdashti F, Rader J, Zoberi I. Grigsby PW, et al. Among authors: zoberi i. Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):706-12. doi: 10.1016/j.ijrobp.2003.12.038. Int J Radiat Oncol Biol Phys. 2004. PMID: 15183474

8

Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer.

Khwaja SS, Ivanovich J, DeWees TA, Ochoa L, Mullen DF, Thomas M, Margenthaler JA, Cyr A, Naughton M, Sanati S, Eberlein TJ, Gillanders WE, Aft RL, Zoberi JE, Zoberi I. Khwaja SS, et al. Among authors: zoberi i, zoberi je. Cancer Med. 2016 Feb;5(2):230-8. doi: 10.1002/cam4.586. Epub 2015 Dec 21. Cancer Med. 2016. PMID: 26687192 Free PMC article.

9

Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast.

Kennedy WR, Gabani P, Acharya S, Thomas MA, Zoberi I. Kennedy WR, et al. Among authors: zoberi i. Cancer Med. 2019 Apr;8(4):1379-1388. doi: 10.1002/cam4.1942. Epub 2019 Mar 12. Cancer Med. 2019. PMID: 30864198 Free PMC article.

10

A treatment planning study comparing HDR and AGIMRT for cervical cancer.

Wahab SH, Malyapa RS, Mutic S, Grigsby PW, Deasy JO, Miller TR, Zoberi I, Low DA. Wahab SH, et al. Among authors: zoberi i. Med Phys. 2004 Apr;31(4):734-43. doi: 10.1118/1.1645678. Med Phys. 2004. PMID: 15124990 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page